Lugosi L
Dev Biol Stand. 1986;58 ( Pt A):15-21.
Hungary has accomplished a resolute BCG programme since 1959 to control tuberculosis in children. High rates of child and adult tuberculosis incidence (over 200 and 300 per hundred thousand respectively) persisted before 1959. At that time the "Budapest" BCG strain received from the Pasteur Institute in 1933 was used for facultative vaccination. In 1954, vaccination became compulsory for the newborn but was not applied regularly with the "Budapest" BCG strain which showed diminished allergenic and immunogenic potency. To improve BCG policy revaccination became obligatory in 1959 up to the age of 20 years performed by specialized BCG nurses. Paris 1102, then P1173 BCG Seed-Lot strains have been used since 1960, dose: 100,000-300,000 VU in 0.1 ml i.d. route to obtain the required protective immunity (tuberculin conversion) and acceptable reactogenicity. In the scope of the systematic BCG primo and revaccination programme 7.8 million vaccinations have been performed since 1959. Between 1959 and 1970 the incidence in children dropped from 250 to 10 per hundred thousand, then to 1 per hundred thousand between 1971 and 1982. In 1982 the adult population had 21-32 per hundred thousand bacillary positive incidence and prevalence rates maintaining the risk of infection for children. Therefore, in 1983, it was decided to continue the compulsory revaccination policy to strengthen immunity for children of 10 years old and for adults of 20 years old.
自1959年以来,匈牙利实施了一项坚定的卡介苗接种计划以控制儿童结核病。1959年之前,儿童和成人结核病发病率一直居高不下(分别超过十万分之200和300)。当时,1933年从巴斯德研究所获得的“布达佩斯”卡介苗菌株用于选择性接种。1954年,新生儿接种卡介苗成为强制性要求,但使用的“布达佩斯”卡介苗菌株未得到定期应用,其变应原性和免疫原性效力有所降低。为改进卡介苗接种政策,1959年起对20岁以下人群实施复种义务制,由专业的卡介苗护士操作。自1960年起使用巴黎1102,后又使用P1173卡介苗种子批菌株,剂量:0.1毫升皮内注射100,000 - 300,000个活菌单位,以获得所需的保护性免疫(结核菌素阳转)和可接受的反应原性。在系统性的卡介苗初种和复种计划范围内,自1959年以来已进行了780万次接种。1959年至1970年间,儿童发病率从十万分之250降至十万分之10,1971年至1982年间又降至十万分之1。1982年,成人人群中每十万人口有21 - 32例菌阳发病率和患病率,儿童仍有感染风险。因此,1983年决定继续实施强制性复种政策,以增强10岁儿童和20岁成人的免疫力。